Internal Medicine, Rheumatology · Fairhope, AL
NPI
1144311663
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3 Medical Park Drive
Fairhope, AL, 36532
Phone (251) 928-8804
Groups this clinician bills Medicare through
Medicare paid, 2024
$565K
65,047 services
Medicare patients, 2024
627
Average age 74
Drug cost, 2024
$7.7M
9,921 prescriptions
Company payments, 2025
$1,948
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William F Sullivan was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 38,400 times for 27 patients. In total William F Sullivan billed 65,047 services in 36 codes, and Medicare paid $565K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 38,400 | 27 | $3.64 | $140K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 3,950 | 11 | $9.26 | $37K |
| J0897 Injection, denosumab, 1 mg | Office | 3,300 | 55 | $18.69 | $62K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,950 | 28 | $24.26 | $72K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2,625 | 12 | $33.27 | $87K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,440 | 34 | $0.10 | $148 |
| 99214 Office E&M - Established | Office | 844 | 416 | $79.44 | $67K |
| 96372 Injection Administration | Office | 183 | 99 | $9.92 | $1,816 |
| 99213 Office E&M - Established | Office | 151 | 125 | $49.15 | $7,422 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 150 | 57 | $0.52 | $78.4 |
| 96415 Chemotherapy Administration | Office | 136 | 28 | $19.22 | $2,614 |
| 99204 Office E&M - New | Office | 120 | 120 | $110.24 | $13K |
| 96413 Chemotherapy Administration | Office | 93 | 36 | $87.96 | $8,180 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 71 | 70 | $11.90 | $845 |
| 96365 Intravenous Infusion, Hydration | Office | 64 | 27 | $42.82 | $2,740 |
By year: 2022 $1.8M for 187,351 services; 2023 $1.7M for 209,994 services; 2024 $565K for 65,047 services.
Medicare prescription drug claims, 2024
In 2024, the drug William F Sullivan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,421 prescriptions and refills. In total William F Sullivan wrote 9,921 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,421 | 3,128 | 433 | $68K |
| Methotrexate Methotrexate Sodium | 1,045 | 1,762 | 316 | $21K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 990 | 990 | 121 | $24K |
| Prednisone Generic | 867 | 1,665 | 305 | $7,058 |
| Gabapentin Generic | 576 | 602 | 99 | $5,052 |
| Tramadol Hcl Generic | 386 | 386 | 71 | $3,009 |
| Humira(Cf) Pen Adalimumab | 308 | 318 | 37 | $2.5M |
| Duloxetine Hcl Generic | 258 | 504 | 77 | $4,385 |
| Folic Acid Generic | 248 | 562 | 73 | $2,114 |
| Leflunomide Generic | 210 | 400 | 84 | $8,073 |
| Allopurinol Generic | 196 | 553 | 61 | $2,858 |
| Mycophenolate Mofetil Generic | 190 | 279 | 44 | $34K |
| Colchicine Generic | 145 | 270 | 62 | $8,286 |
| Celecoxib Generic | 142 | 308 | 53 | $4,693 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 138 | 138 | 17 | $3,455 |
Brand drugs: 1,399 claims; generic drugs: 8,487 claims; opioid claims: 1,629.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William F Sullivan $1,948 ($1,948 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $553.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $553 |
| UCB, Inc. UCB.BR | 14 | $293 |
| Genzyme Corporation SNY | 6 | $235 |
| Amgen Inc. AMGN | 11 | $183 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $163 |
| Lilly USA, LLC LLY | 5 | $107 |
| Radius Health, Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $100 |
| GlaxoSmithKline, LLC. GSK | 4 | $99.51 |
| Janssen Biotech, Inc. JNJ | 4 | $69.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.